Annual EBIT
-$6.32 M
+$2.33 M+26.91%
September 30, 2024
Summary
- As of February 12, 2025, EDSA annual earnings before interest & taxes is -$6.32 million, with the most recent change of +$2.33 million (+26.91%) on September 30, 2024.
- During the last 3 years, EDSA annual EBIT has risen by +$7.02 million (+52.65%).
- EDSA annual EBIT is now -8447.36% below its all-time high of -$73.90 thousand, reached on April 30, 2009.
Performance
EDSA EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$967.20 K
+$729.00 K+42.98%
September 30, 2024
Summary
- As of February 12, 2025, EDSA quarterly earnings before interest & taxes is -$967.20 thousand, with the most recent change of +$729.00 thousand (+42.98%) on September 30, 2024.
- Over the past year, EDSA quarterly EBIT has increased by +$949.30 thousand (+49.53%).
- EDSA quarterly EBIT is now -179.45% below its all-time high of $1.22 million, reached on August 31, 2011.
Performance
EDSA Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$6.32 M
+$821.40 K+11.51%
September 30, 2024
Summary
- As of February 12, 2025, EDSA TTM earnings before interest & taxes is -$6.32 million, with the most recent change of +$821.40 thousand (+11.51%) on September 30, 2024.
- Over the past year, EDSA TTM EBIT has increased by +$1.19 million (+15.85%).
- EDSA TTM EBIT is now -14420.69% below its all-time high of -$43.50 thousand, reached on October 31, 2009.
Performance
EDSA TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
EDSA EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +26.9% | +49.5% | +15.8% |
| 3 y3 years | +52.6% | +53.1% | +34.8% |
| 5 y5 years | -123.0% | +53.1% | +34.8% |
EDSA EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +64.1% | at high | +83.3% | at high | +65.6% |
| 5 y | 5-year | -123.0% | +64.1% | at high | +83.3% | -28.6% | +65.6% |
| alltime | all time | -8447.4% | +64.1% | -179.4% | +83.3% | <-9999.0% | +65.6% |
Edesa Biotech EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | -$6.32 M(-26.9%) | -$967.20 K(-43.0%) | -$6.32 M(-11.5%) |
| Jun 2024 | - | -$1.70 M(-11.5%) | -$7.14 M(-4.9%) |
| Mar 2024 | - | -$1.92 M(+10.4%) | -$7.51 M(-6.2%) |
| Dec 2023 | - | -$1.74 M(-2.9%) | -$8.00 M(-7.4%) |
| Sep 2023 | -$8.64 M(-50.9%) | -$1.79 M(-13.4%) | -$8.64 M(-10.8%) |
| Jun 2023 | - | -$2.06 M(-14.4%) | -$9.69 M(-27.8%) |
| Mar 2023 | - | -$2.41 M(+1.4%) | -$13.42 M(-13.9%) |
| Dec 2022 | - | -$2.38 M(-16.1%) | -$15.59 M(-11.4%) |
| Sep 2022 | -$17.59 M(+31.9%) | -$2.84 M(-51.1%) | -$17.59 M(-4.3%) |
| Jun 2022 | - | -$5.80 M(+26.7%) | -$18.38 M(+5.9%) |
| Mar 2022 | - | -$4.58 M(+4.4%) | -$17.34 M(+14.8%) |
| Dec 2021 | - | -$4.38 M(+21.0%) | -$15.11 M(+13.3%) |
| Sep 2021 | -$13.34 M(+108.4%) | -$3.62 M(-24.0%) | -$13.34 M(+13.7%) |
| Jun 2021 | - | -$4.77 M(+103.7%) | -$11.73 M(+34.3%) |
| Mar 2021 | - | -$2.34 M(-10.5%) | -$8.73 M(+10.4%) |
| Dec 2020 | - | -$2.61 M(+30.0%) | -$7.91 M(+23.6%) |
| Sep 2020 | -$6.40 M(+126.0%) | -$2.01 M(+13.7%) | -$6.40 M(+19.4%) |
| Jun 2020 | - | -$1.77 M(+16.6%) | -$5.36 M(+9.1%) |
| Mar 2020 | - | -$1.52 M(+37.1%) | -$4.91 M(-3.3%) |
| Dec 2019 | - | -$1.11 M(+13.9%) | -$5.08 M(-5.6%) |
| Sep 2019 | -$2.83 M(-44.2%) | -$971.00 K(-26.5%) | -$5.38 M(-3.8%) |
| Jun 2019 | - | -$1.32 M(-21.6%) | -$5.60 M(+3.0%) |
| Mar 2019 | - | -$1.68 M(+19.7%) | -$5.43 M(+6.7%) |
| Dec 2018 | - | -$1.41 M(+18.6%) | -$5.09 M(+0.3%) |
| Sep 2018 | -$5.08 M(-2.8%) | -$1.19 M(+2.4%) | -$5.08 M(-3.5%) |
| Jun 2018 | - | -$1.16 M(-13.8%) | -$5.26 M(-2.5%) |
| Mar 2018 | - | -$1.34 M(-3.3%) | -$5.40 M(+3.8%) |
| Dec 2017 | - | -$1.39 M(+1.5%) | -$5.20 M(-0.5%) |
| Sep 2017 | -$5.22 M(+6.4%) | -$1.37 M(+5.8%) | -$5.22 M(+1.0%) |
| Jun 2017 | - | -$1.29 M(+12.7%) | -$5.17 M(+2.1%) |
| Mar 2017 | - | -$1.15 M(-18.9%) | -$5.07 M(+1.0%) |
| Dec 2016 | - | -$1.41 M(+7.4%) | -$5.02 M(+2.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2016 | -$4.91 M(+13.1%) | -$1.32 M(+10.8%) | -$4.91 M(+8.1%) |
| Jun 2016 | - | -$1.19 M(+8.4%) | -$4.54 M(+7.4%) |
| Mar 2016 | - | -$1.10 M(-16.2%) | -$4.23 M(-2.2%) |
| Dec 2015 | - | -$1.31 M(+37.9%) | -$4.32 M(-0.4%) |
| Sep 2015 | -$4.34 M(+859.2%) | -$948.00 K(+8.3%) | -$4.34 M(-6.8%) |
| Jun 2015 | - | -$875.60 K(-26.4%) | -$4.65 M(-9.4%) |
| Mar 2015 | - | -$1.19 M(-10.2%) | -$5.14 M(-4.7%) |
| Dec 2014 | - | -$1.33 M(+4.8%) | -$5.39 M(-5.7%) |
| Sep 2014 | -$452.30 K(-92.1%) | - | - |
| Aug 2014 | -$5.72 M(+48.6%) | -$1.26 M(-7.0%) | -$5.72 M(-0.7%) |
| May 2014 | - | -$1.36 M(-5.8%) | -$5.76 M(+11.0%) |
| Feb 2014 | - | -$1.44 M(-12.5%) | -$5.19 M(+13.0%) |
| Nov 2013 | - | -$1.65 M(+26.4%) | -$4.59 M(+19.4%) |
| Aug 2013 | -$3.85 M(-41.2%) | -$1.31 M(+65.5%) | -$3.85 M(-10.3%) |
| May 2013 | - | -$789.10 K(-7.0%) | -$4.29 M(-16.2%) |
| Feb 2013 | - | -$848.60 K(-6.2%) | -$5.12 M(-10.0%) |
| Nov 2012 | - | -$904.40 K(-48.3%) | -$5.69 M(-13.0%) |
| Aug 2012 | -$6.55 M(+35.5%) | -$1.75 M(+7.8%) | -$6.55 M(+82.8%) |
| May 2012 | - | -$1.62 M(+14.1%) | -$3.58 M(+9.2%) |
| Feb 2012 | - | -$1.42 M(-19.1%) | -$3.28 M(-43.4%) |
| Nov 2011 | - | -$1.76 M(-244.2%) | -$5.79 M(+19.8%) |
| Aug 2011 | -$4.83 M(+726.5%) | $1.22 M(-192.3%) | -$4.83 M(-22.2%) |
| May 2011 | - | -$1.32 M(-66.4%) | -$6.21 M(+18.8%) |
| Feb 2011 | - | -$3.93 M(+392.3%) | -$5.23 M(+300.2%) |
| Nov 2010 | - | -$798.50 K(+402.5%) | -$1.31 M(+140.0%) |
| Aug 2010 | -$584.60 K(+691.1%) | -$158.90 K(-52.9%) | -$544.00 K(+41.3%) |
| May 2010 | - | -$337.10 K(+2883.2%) | -$385.10 K(+681.1%) |
| Jan 2010 | - | -$11.30 K(-69.2%) | -$49.30 K(+13.3%) |
| Oct 2009 | - | -$36.70 K(+2723.1%) | -$43.50 K(-40.5%) |
| Apr 2009 | -$73.90 K | -$1300.00(-76.4%) | -$73.10 K(+1.8%) |
| Jan 2009 | - | -$5500.00(-91.7%) | -$71.80 K(+8.3%) |
| Oct 2008 | - | -$66.30 K | -$66.30 K |
FAQ
- What is Edesa Biotech annual earnings before interest & taxes?
- What is the all time high annual EBIT for Edesa Biotech?
- What is Edesa Biotech annual EBIT year-on-year change?
- What is Edesa Biotech quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Edesa Biotech?
- What is Edesa Biotech quarterly EBIT year-on-year change?
- What is Edesa Biotech TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Edesa Biotech?
- What is Edesa Biotech TTM EBIT year-on-year change?
What is Edesa Biotech annual earnings before interest & taxes?
The current annual EBIT of EDSA is -$6.32 M
What is the all time high annual EBIT for Edesa Biotech?
Edesa Biotech all-time high annual earnings before interest & taxes is -$73.90 K
What is Edesa Biotech annual EBIT year-on-year change?
Over the past year, EDSA annual earnings before interest & taxes has changed by +$2.33 M (+26.91%)
What is Edesa Biotech quarterly earnings before interest & taxes?
The current quarterly EBIT of EDSA is -$967.20 K
What is the all time high quarterly EBIT for Edesa Biotech?
Edesa Biotech all-time high quarterly earnings before interest & taxes is $1.22 M
What is Edesa Biotech quarterly EBIT year-on-year change?
Over the past year, EDSA quarterly earnings before interest & taxes has changed by +$949.30 K (+49.53%)
What is Edesa Biotech TTM earnings before interest & taxes?
The current TTM EBIT of EDSA is -$6.32 M
What is the all time high TTM EBIT for Edesa Biotech?
Edesa Biotech all-time high TTM earnings before interest & taxes is -$43.50 K
What is Edesa Biotech TTM EBIT year-on-year change?
Over the past year, EDSA TTM earnings before interest & taxes has changed by +$1.19 M (+15.85%)